glp 1 agonist alcohol use disorder Frontiers GLP-1 Agonists Like Semaglutide Show
Description
Arq Bras Endocrinol Metab
Metabolic syndrome with elevated liver enzymes : Patients presenting with multiple metabolic risk factors (central obesity, hypertension, dyslipidemia, impaired fasting glucose) and persistently elevated ALT/AST may benefit from the comprehensive metabolic improvements offered by GLP-1 therapy
Schaffer C, Buclin T, Jornayvaz FR, et al
2025 July 8;26345161251353437
By Primary Use FDA-approved indications are product-specific and based on clinical trial data for each formulation and dose
Maselli D, Atieh J, Clark MM, Eckert D, Taylor A, Carlson P, et al
